(4S,5R)-2-((S)-2-(Diphenylphosphanyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-4,5-diphenyl-4,5-dihydrooxazole

Catalog No. :
ACUOOL854
CAS No. :
2757084-27-6
Molecular Formula :
C36H31N2OP
Molecular Weight :
538.63

IUPAC Name:(4S,5R)-2-((S)-2-(diphenylphosphaneyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-4,5-diphenyl-4,5-dihydrooxazole

(4S,5R)-2-((S)-2-(Diphenylphosphanyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-4,5-diphenyl-4,5-dihydrooxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$1098.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4S,5R)-2-((S)-2-(Diphenylphosphanyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-4,5-diphenyl-4,5-dihydrooxazole
IUPAC Name(4S,5R)-2-((S)-2-(diphenylphosphaneyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-4,5-diphenyl-4,5-dihydrooxazole
Molecular FormulaC36H31N2OP
Molecular Weight538.63
SMILESC1([C@H]2N(P(C3=CC=CC=C3)C4=CC=CC=C4)CC5=C(C=CC=C5)C2)=N[C@@H](C6=CC=CC=C6)[C@@H](C7=CC=CC=C7)O1
InChI KeyKMAGVECZTDMKCR-PUPDPRJKSA-N
SynonymIsoquinoline, 3-[(4S,5R)-4,5-dihydro-4,5-diphenyl-2-oxazolyl]-2-(diphenylphosphino)-1,2,3,4-tetrahydro-, (3S)-
CAS No.2757084-27-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H319-H413
Precautionary Statement(s)
P264-P273-P280-P305+P351+P338-P337+P313-P501

Synthetic Route by SureRoute

1. ACUOOL854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUOOL854 route product structure diagram
    ACUOOL8542757084-27-6
Inquiry

2. ACUOOL854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUOOL854 route product structure diagram
    ACUOOL8542757084-27-6
Inquiry

Comments (0)